Inventor · disambiguated record
Xing Yang
Also filed as: YANG XING · Yang xing xing
12 granted patents·19 pending applications·29 citations·filing 2004–2025
86Inventor score
Files withUNIV JOHNS HOPKINS19HAINAN YANGPU NEW SPECIAL PHAR2LANZHOU VETERINARY RES INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES1OPTIMUMNANO ENERGY CO LTD1SHANXI TAIGANG STAINLESS STEEL PREC STRIP CO LTD1
Top patents by PatentIndex Score
31 records- 0192US10736974B2Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapyUNIV JOHNS HOPKINS·Filed 2015·Granted Aug 11, 2020·4 cites·1 claims
- 0291US10683272B2Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapyUNIV JOHNS HOPKINS·Filed 2015·Granted Jun 16, 2020·5 cites·20 claims
- 0389US10688198B2Salicylic acid-based polymeric CEST contrast agents targeting prostate-specific membrane antigen and uses thereofUNIV JOHNS HOPKINS·Filed 2016·Granted Jun 23, 2020·4 cites·40 claims
- 0484US2025230135A1Metal/radiometal-labeled psma inhibitors for psma-targeted imaging and radiotherapyUNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 0583US12115233B2Imaging and radiotherapeutics agents targeting fibroblast-activation protein-α (FAP-α)UNIV JOHNS HOPKINS·Filed 2024·Granted Oct 15, 2024·0 cites·4 claims
- 0683US2025186628A1Imaging and radiotherapeutics agents targeting fibroblast-activation protein-alpha (fap-alpha)UNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 0780US11938201B2Imaging and radiotherapeutics agents targeting fibroblast-activation protein-alpha (FAP-alpha)UNIV JOHNS HOPKINS·Filed 2023·Granted Mar 26, 2024·0 cites·3 claims
- 0875US2025235565A1Imaging and radiotherapeutics agents targeting fibroblast-activation protein-alpha (fap-alpha)UNIV JOHNS HOPKINS·Filed 2025·Application pending·0 cites
- 0974US2022135529A1Metal/radiometal-labeled psma inhibitors for psma-targeted imaging and radiotherapyUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 1069US10188754B2Compositions and methods for chemical exchange saturation transfer (CEST) based magnetic resonance imaging (MRI)UNIV JOHNS HOPKINS·Filed 2014·Granted Jan 29, 2019·4 cites·13 claims
- 1167US11911488B2Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapyUNIV JOHNS HOPKINS·Filed 2020·Granted Feb 27, 2024·0 cites·4 claims
- 1267US2020330624A1Imaging and radiotherapeutics agents targeting fibroblast-activation protein-alpha (fap-alpha)UNIV JOHNS HOPKINS·Filed 2018·Application pending·0 cites
- 1367US2020290982A1Metal/radiometal-labeled psma inhibitors for psma-targeted imaging and radiotherapyUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 1462US11987797B2Attenuated strain of African swine fever virus (ASFV) with IPTG-induced deletion of D1133L gene and use thereofLANZHOU VETERINARY RES INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES·Filed 2022·Granted May 21, 2024·0 cites·8 claims
- 1560US2020330613A1Salicylic acid-based polymeric cest contrast agents targeting prostate-specific membrane antigen and uses thereofUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 1659US2024398999A1Dc biomimetic membrane nanoparticle loaded with nir-ii aie dye, preparation method therefor and use thereofSHENZHEN INST OF ADV TECH CAS·Filed 2023·Application pending·0 cites
- 1758US2024058507A1A biomaterial with a high glycosaminoglycan/hydroxyproline ratio, composition, methods and applicationsUNIV HONG KONG·Filed 2022·Application pending·0 cites
- 1857US11078166B2Triazole conjugated ureas, thioureas, carbamates, and reversed carbamates for PSMA-targeted imaging agents and uses thereofUNIV JOHNS HOPKINS·Filed 2016·Granted Aug 3, 2021·0 cites·1 claims
- 1955USD712406SElectronic deviceSYNERGY OPTOELECTRONICS SHENZHEN CO LTD·Filed 2013·Granted Sep 2, 2014·12 cites·1 claims
- 2055US2022062346A1USE OF miRNA IN PREPARATION OF A DRUG FOR PREVENTING AND TREATING OSTEOARTHRITIS, AN EXOSOME HIGHLY EXPRESSING miRNA AND USE THEREOFSUZHOU MUNICIPAL HOSPITAL NORTH DISTR·Filed 2021·Application pending·0 cites
- 2153US2022355355A1Ultra-thin precision stainless steel foil with high strength and high plasticity and production method thereofSHANXI TAIGANG STAINLESS STEEL PREC STRIP CO LTD·Filed 2021·Application pending·0 cites
- 2252US2024408248A1Granzyme b-targeting complex, radiopharmaceutical, preparation method therefor and use thereofUNIV BEIJING·Filed 2022·Application pending·0 cites
- 2349US2009253742A1Marasmius androsaceus l.es fr extract, piperidone derivative, and their use for the preparation of antihypertensivesHAINAN YANGPU NEW SPECIAL PHAR·Filed 2009·Application pending·0 cites
- 2448US2007099194A1Quality control of probe attachment on electrodesYANG XING·Filed 2005·Application pending·0 cites
- 2547US2016075667A1Compositions and methods for chemical exchange saturation transfer (cest) magnetic resonance imaging (mri)UNIV JOHNS HOPKINS·Filed 2014·Application pending·0 cites
- 2646US7608630B2Marasmius androsaceus L.es Fr extract, piperidone derivative, and their use for the preparation of hypertensivesHAINAN YANGPU NEW SPECIAL PHAR·Filed 2004·Granted Oct 27, 2009·0 cites·9 claims
- 2741US2019036163A1Method for preparing composite solid state electrolyteOPTIMUMNANO ENERGY CO LTD·Filed 2018·Application pending·0 cites
- 2838US2019192699A1Nuclear imaging and radiotherapeutics agents targeting carbonic anhydrase ix and uses thereofUNIV JOHNS HOPKINS·Filed 2017·Application pending·0 cites
- 2937US10857246B2Nuclear imaging and radiotherapeutics agents targeting carbonic anhydrase IX and uses thereofUNIV JOHNS HOPKINS·Filed 2016·Granted Dec 8, 2020·0 cites·27 claims
- 3037US2018222922A1Radiofluorinated 7-amino-5-thio-thiazolo[4,5-d]pyrimidines for imaging fractalkine receptor (cx3cr1)UNIV JOHNS HOPKINS·Filed 2016·Application pending·0 cites
- 3135US2023414794A1Psma inhibitor, compound and applicationUNIV PEKING FIRST HOSPITAL·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xing Yang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →